Medicare Enrolled

Dr. Daniel Ross, M.D.

Ophthalmology · Allentown, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1739 W FAIRMONT ST, Allentown, PA 18104
6104374988
In practice since 2005 (20 years)
NPI: 1609876994 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ross from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ross? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ross

Dr. Daniel Ross is an ophthalmology specialist in Allentown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ross performed 11,124 Medicare services across 3,183 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ross received a total of $3,172 from 33 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ross is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 9% volume in PA $3,172 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,124
Medicare services
Top 9% in PA for ophthalmology
3,183
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~556 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
7,260 $29 $40
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,010 $79 $144
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
913 $27 $68
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
504 $26 $85
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
269 $90 $134
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
194 $86 $262
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
139 $408 $1,500
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
137 $95 $164
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
128 $36 $130
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
120 $63 $94
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
107 $43 $98
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
97 $32 $102
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
58 $23 $68
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
40 $239 $833
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
35 $92 $139
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
30 $57 $85
Laser repair to improve eye fluid flow
A laser procedure used to enhance the drainage of fluid within the eye.
27 $185 $750
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
19 $120 $184
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
13 $21 $55
New patient office visit, complex (60-74 min) 13 $145 $219
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $40 $60
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
77.5% medium
21.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,172
Total received (2018-2024)
Avg $453/year across 7 years
Top 27% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
160
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,022 (95.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$150 (4.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$753
2023
$565
2022
$475
2021
$575
2020
$182
2019
$373
2018
$248

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$167
Cardinal Health 110 LLC
$150
Apellis Pharmaceuticals, Inc.
$73
Alimera Sciences, Inc.
$58
Alcon Vision LLC
$58
Regeneron Healthcare Solutions, Inc.
$55
Bausch & Lomb Americas Inc.
$52
Genentech USA, Inc.
$44
Astellas Pharma US Inc
$35
Oyster Point Pharma, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
BIOTISSUE HOLDINGS INC.
$13
Top 3 companies account for 51.8% of 2024 payments
All-time payments by company (2018-2024) ›
EyePoint Pharmaceuticals US, Inc.
$346
Alcon Vision LLC
$327
ABBVIE INC.
$246
Genentech USA, Inc.
$241
Regeneron Healthcare Solutions, Inc.
$174
Cardinal Health 110 LLC
$150
Allergan, Inc.
$143
Alimera Sciences, Inc.
$140
Alcon Laboratories Inc
$137
Sun Pharmaceutical Industries Inc.
$132
Omeros Corporation
$123
Novartis Pharmaceuticals Corporation
$117
Bausch & Lomb Americas Inc.
$100
Oyster Point Pharma, Inc.
$96
SUN PHARMACEUTICAL INDUSTRIES INC.
$76
Apellis Pharmaceuticals, Inc.
$73
Kala Pharmaceuticals, Inc.
$66
Allergan Inc.
$61
Horizon Therapeutics plc
$57
Astellas Pharma US Inc
$53
Ocular Therapeutix, Inc.
$38
Sight Sciences, Inc.
$35
Rayner Intraocular Lenses Limited
$33
Bausch & Lomb, a division of Bausch Health US, LLC
$33
Shire North American Group Inc
$32
Johnson & Johnson Surgical Vision, Inc.
$27
Johnson & Johnson Vision Care, Inc.
$25
Celularity Inc.
$18
Aerie Pharmaceuticals, Inc.
$16
GLAUKOS CORPORATION
$16
Mallinckrodt Enterprises LLC
$14
BIOTISSUE HOLDINGS INC.
$13
Vyera Pharmaceuticals, LLC
$12
Top 3 companies account for 29.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · Acuvue · CEQUA · COMBIGAN · Cequa · Clareon · CyPass · DEXTENZA · DEXYCU · DURYSTA · Daraprim 30 Tablet in 1 Bottle · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · IACCESS · ILUVIEN · INVELTYS · Izervay · LUMIGAN · Lucentis · Luxor · OMNI · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · Omidria · PROLENSA · PanOptix · RESTASIS · RESTASIS MULTIDOSE · ReSTOR · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis iTec Preloaded Delivery System · VABYSMO · VUITY · VYZULTA · Vabysmo · XELPROS · XIIDRA · XIPERE · YUTIQ · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Allentown?
Compare ophthalmologists in the Allentown area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
60
Per 100K population
16.0
County median income
$77,493
Nearest hospital
LEHIGH VALLEY HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ross is a mixed practice specialist, with above-average Medicare volume (top 9% in PA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ross experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Ross performed 7,260 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ross receive payments from pharmaceutical companies?
Yes. Dr. Ross received a total of $3,172 from 33 companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ross's costs compare to other ophthalmologists in Allentown?
Dr. Ross's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ross) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →